Biological rationale for a patient-specific approach in the treatment of breast cancer. Clinical value of novel biomarkers of breast cancer
Breast cancer, being the most common type of malignant diseases, remains a significant challenge for both clinicians and fundamental researchers. The implementation of screening mammography, as well as adjuvant and neoadjuvant systemic therapy has made a significant progress in tackling the disease....
Saved in:
Main Author: | R. M. Paltuev |
---|---|
Format: | Article |
Language: | Russian |
Published: |
ABV-press
2019-09-01
|
Series: | Опухоли женской репродуктивной системы |
Subjects: | |
Online Access: | https://ojrs.abvpress.ru/ojrs/article/view/645 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Omitting anthracyclines for the adjuvant treatment of patients with triple-negative breast cancer: A non-inferiority meta-analysis
by: Fabio Girardi, et al.
Published: (2025-10-01) -
Molecular genetic predictors of progression of triple negative breast cancer
by: I. S. Panchenko, et al.
Published: (2025-03-01) -
The role of epidermal growth factor receptor (EGFR) in the efficacy of neoadjuvant chemotherapy in triple-negative breast cancer patients
by: N. N. Babyshkina, et al.
Published: (2020-04-01) -
Results of combination treatment for triple-negative breast cancer
by: M. A. Sekundova, et al.
Published: (2014-07-01) -
Treatment of thrice-negative breast cancer in a patient with metabolic syndrome
by: G. E. Roitberg, et al.
Published: (2021-03-01)